THOMAS A BUCHHOLZ to Cost-Benefit Analysis
This is a "connection" page, showing publications THOMAS A BUCHHOLZ has written about Cost-Benefit Analysis.
Connection Strength
0.325
-
Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing. Brachytherapy. 2016 May-Jun; 15(3):274-282.
Score: 0.102
-
Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults. J Geriatr Oncol. 2015 Jul; 6(4):324-31.
Score: 0.098
-
Economic burden of renal cell carcinoma: Part I--an updated review. Pharmacoeconomics. 2011 Apr; 29(4):315-29.
Score: 0.073
-
Cost-effectiveness of posttreatment surveillance after radiation therapy for early stage seminoma. Cancer. 1998 Mar 15; 82(6):1126-33.
Score: 0.029
-
Survival and cost-effectiveness of hospice care for metastatic melanoma patients. Am J Manag Care. 2014 May; 20(5):366-73.
Score: 0.023